BioHealth News Archive

FounderTrac Demo Day

FounderTrac Demo Day

Tuesday ,November 6, 2018 6:15 PM - 8:30 PM, Hotel Annapolis126 West StreetAnnapolis, MD 21401 FounderTrac invites you to Demo Day! The FounderTrac accelerator ‘connects…

Read More
OpGen Collaborates With QIAGEN to Advance Rapid Diagnostics for Antimicrobial Resistant Bacteria Nasdaq:OPGN

OpGen Collaborates With QIAGEN to Advance Rapid Diagnostics for Antimicrobial Resistant Bacteria Nasdaq:OPGN

OpGen, Inc. (NASDAQ: OPGN) today announced a collaboration with QIAGEN N.V. to advance rapid diagnostics for antimicrobial resistance (AMR). Strengthening OpGen’s entry into the…

Read More
TaiRx looks to commercialize therapy targeting drug-resistant cancers – Washington Business Journal

TaiRx looks to commercialize therapy targeting drug-resistant cancers – Washington Business Journal

TaiRx, a joint venture between Rockville-based BioHealth Innovation Inc. and Taiwan pharmaceutical company TaiRx Inc., is looking to raise around $5 million. {iframe}https://www.bizjournals.com/washington/news/2018/10/31/how-maryland-s-newest-company-plans-to-take-down.html{/iframe}

Read More
Washington Business Journal Recognizes Emmes in Two “Top Company” Lists

Washington Business Journal Recognizes Emmes in Two “Top Company” Lists

The Emmes Corporation today announced that it was named one of the largest women-owned businesses in the Washington metropolitan area by the Washington Business…

Read More
Here’s how an AstraZeneca spinout deal gets done – Baltimore Business Journal

Here’s how an AstraZeneca spinout deal gets done – Baltimore Business Journal

AstraZeneca PLC’s research and development arm MedImmune Inc. spun off a small biotech startup company called Viela Bio. {iframe}https://www.bizjournals.com/baltimore/news/2018/10/30/here-s-how-an-astrazeneca-spinout-deal-gets-done.html{/iframe}

Read More
What’s next for RightEye following FDA approval – Washington Business Journal

What’s next for RightEye following FDA approval – Washington Business Journal

Bethesda health tech company RightEye LLC is finally moving beyond the research and development phase. {iframe}https://www.bizjournals.com/washington/news/2018/10/30/righteye-got-its-fda-approval-here-s-what-s-next.html?ana=e_du_prem&s=article_du&ed=2018-10-30&u=fQFLvOpMSMnvK7iAcBsVng0eb45ba2&t=1541423895&j=84729071{/iframe}

Read More
Alexandria Real Estate’s Marcus on Interest Rates, Drug Pricing – Bloomberg

Alexandria Real Estate’s Marcus on Interest Rates, Drug Pricing – Bloomberg

Joel Marcus, chairman at Alexandria Real Estate Equities, discusses the risk of rising interest rates, how government action on drug pricing could impact the…

Read More
TEDCO’s Builder Fund is closing the investment gap for more entrepreneurs – Technical.ly DC

TEDCO’s Builder Fund is closing the investment gap for more entrepreneurs – Technical.ly DC

Although we’re told business isn’t personal, the reality is that business is built on relationships. In other words, it’s not what you know, it’s…

Read More
QIAGEN expands QIAGEN Clinical Insight software to support all major sequencing platforms and assay types

QIAGEN expands QIAGEN Clinical Insight software to support all major sequencing platforms and assay types

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of major enhancements to QIAGEN Clinical Insight (QCI) bioinformatics solutions to deliver…

Read More
CEL-SCI RECEIVES ABOUT $8 MILLION FROM WARRANT EXERCISES

CEL-SCI RECEIVES ABOUT $8 MILLION FROM WARRANT EXERCISES

CEL-SCI Corporation (NYSE American: CVM) announced today it has received just under $8 million through the exercise of warrants to purchase shares of the…

Read More
Neuralstem Announces $2.1 Million Registered Direct Offering

Neuralstem Announces $2.1 Million Registered Direct Offering

Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on developing novel treatments for nervous system diseases, today announced that it has entered into definitive agreements…

Read More
RegeneRx Partner Updates on Clinical Trials – Oct 29, 2018

RegeneRx Partner Updates on Clinical Trials – Oct 29, 2018

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced a…

Read More
Biobuzz Directory – Epigenomics AG Obtains CE Mark for Liquid Biopsy Test for Liver Cancer Detection

Biobuzz Directory – Epigenomics AG Obtains CE Mark for Liquid Biopsy Test for Liver Cancer Detection

Epigenomics AG (FSE: ECX, OTCQX: EPGNY) today announced that it has received CE Mark for its blood test to aid in detecting liver cancer…

Read More
Local entrepreneurs enter shark tank at Shore Hatchery – 47abc

Local entrepreneurs enter shark tank at Shore Hatchery – 47abc

The Shore Hatchery here at Salisbury University has become one of the premiere opportunities for local entrepreneurs and Friday over a dozen were making…

Read More
Aledade raises $23 million — again – Washington Business Journal

Aledade raises $23 million — again – Washington Business Journal

The new funding includes a $15 million investment from Palo Alto-based Meritech Capital Partners. {iframe}https://www.bizjournals.com/washington/news/2018/10/17/bethesda-health-tech-company-aledade-raises-23.html{/iframe}

Read More